InnoCare Pharma Limited’s $287 Million Initial Public Offering

Davis Polk and Ogier advised InnoCare Pharma Limited on the deal. InnoCare Pharma Limited executed its initial public offering and listing on the Hong Kong Stock…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Maha Kanaan

Author: Maha Kanaan

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here